Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bio-Techne Q2 Adj EPS $0.40 Misses $0.41 Estimate, Sales $272.60M Miss $277.53M Estimate

Author: Benzinga Newsdesk | February 01, 2024 07:31am
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.41 by 2.44 percent. This is a 14.89 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $272.60 million which missed the analyst consensus estimate of $277.53 million by 1.78 percent. This is a 0.37 percent increase over sales of $271.58 million the same period last year.

Posted In: TECH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist